PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-6.41%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-9.65%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-5.60%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
0.86%
Margin expansion 50-75% of CRWV's 1.30%. Martin Whitman would scrutinize competitive position.
2.11%
R&D change of 2.11% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-23.96%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-19.45%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-49.83%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
5.17%
EBITDA growth below 50% of CRWV's 33.05%. Michael Burry would check for structural issues.
11.83%
EBITDA margin growth exceeding 1.5x CRWV's 7.69%. David Dodd would verify competitive advantages.
16.09%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
24.03%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
41.09%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
19.93%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
28.14%
Similar pre-tax margin growth to CRWV's 26.86%. Walter Schloss would investigate industry trends.
19.93%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
19.93%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
28.14%
Net margin growth 1.25-1.5x CRWV's 25.27%. Bruce Berkowitz would examine sustainability.
19.05%
Similar EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
19.05%
Similar diluted EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
0.37%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
0.15%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.